Brief: Hyphens Pharma International Attracts S$6 Mln Investment In Docmed Technology
27/05/2022 02:23
May 27 (Reuters) - Hyphens Pharma International Ltd
HYPH.SI :
* ATTRACTS S$6 MILLION INVESTMENT IN DOCMED TECHNOLOGY
* SIGNED SUBSCRIPTION DEAL WITH DOCMED TECHNOLOGY, WHERE
METRO
HOLDINGS WILL BE INVESTING S$6 MILLION FOR 10% STAKE IN DOCMED
Source text for Eikon: ID:nSN1y2Ydf
Further company coverage: HYPH.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyphens Pharma International
See all newsBrief: Hyphens Pharma International Updates On Cerapro® Med Skin Barrier Cream
Brief: Hyphens Pharma International Says Unit Gets Exclusive Rights To Commercialise Metoject
Brief: Hyphens Pharma International Posts FY Net Income Of SGD 10.9 Million
Brief: Hyphens Pharma International Licenses Amenalief From Maruho For ASEAN
Brief: Hyphens Pharma International Posts Net Profit After Tax In 1Q2024 S$2.7 Million